KSENIJA KOS: Open Payments
NPI 1265454987 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,415 in 59 payments from 19 companies in 2025. Trend: 2023 $706 · 2024 $3,004 · 2025 $1,415
Food & beverage: $1,415
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $443 |
| Vanda Pharmaceuticals Inc. | 10 | $191 |
| EMD Serono, Inc. | 2 | $131 |
| TG Therapeutics, Inc. | 1 | $119 |
| Lilly USA, LLC | 5 | $100 |
| Biogen, Inc. | 3 | $69 |
| Grifols USA, LLC | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Amneal Pharmaceuticals LLC | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $30 |
Products named: PONVORY, BOTOX, BRIUMVI, UBRELVY, VYALEV, KISUNLA, QULIPTA, TYSABRI.
Industry payments across MO — which companies pay providers there.
